News

(Orlando, Fla.) Nov. 10, 2023 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the nine months ended Sept. 30, 2023. […]

(Orlando, Fla.) Oct. 24, 2023 — CNL Strategic Capital, LLC acquired a majority equity stake and made a concurrent debt investment in Sill Public Adjusters (Sill) in partnership with Sill’s management. This is the 13th company in CNL Strategic Capital’s portfolio. Founded in 1928 and headquartered in Cleveland, Ohio, Sill is among the leading specialty

(Orlando, Fla.) Aug. 11, 2023 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the six months ended June 30,

(Orlando, Fla.) May 15, 2023 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the three months ended March 31,

(Orlando, Fla.) March 30, 2023 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2022.

(Orlando, Fla.) March 27, 2023 — CNL Strategic Capital, LLC acquired a majority equity stake and made a concurrent debt investment in TacMed Solutions (TacMed). At the closing of the transaction, all of the remaining TacMed equity is owned by members of TacMed’s executive team and its founder. This is the 12th company in CNL

(Orlando, Fla.) Jan. 6, 2023 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the nine months ended Sept. 30,

(Orlando, Fla.) Aug. 26 2022 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the six months ended June 30,

(Orlando, Fla.) May 10, 2022 — CNL Strategic Capital, LLC acquired a majority equity stake and made a concurrent debt investment in Vektek Holdings, LLC. At the closing of the transaction, substantially all of the remaining Vektek equity is owned by certain of the pre-closing members of Vektek. This is the 11th company in CNL

(Orlando, Fla.) April 7, 2022 — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2021,